Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRAEMIUM LIMITED Capital/Financing Update 2011

Nov 9, 2011

65606_rns_2011-11-09_383e85f9-e7ce-401a-97f1-7ce122d5bf1b.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

Praemium Limited

ABN

74 098 405 826

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of +securities issued or to Ordinary Shares be issued 2 Number of[+] securities issued or 66,667 Ordinary Shares to be issued (if known) or maximum number which may be issued 3 Principal terms of the[+] securities Fully paid ordinary shares issued, issued to UK (eg, if options, exercise price and staff on vesting of Performance Rights (UK EMI expiry date; if partly paid Options). +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

  • See chapter 19 for defined terms.

Appendix 3B Page 1

1/1/2003

4
Do the+securities rank equally in
all respects from the date of
allotment with an existing+class
of quoted+securities?
If the additional securities do not
rank equally, please state:
the date from which they do
the extent to which they
participate
for
the
next
dividend, (in the case of a
trust, distribution) or interest
payment
the extent to which they do
not rank equally, other than in
relation to the next dividend,
distribution
or
interest
payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the
acquisition of assets,
clearly
identify those assets)
7
Dates of entering+securities
into uncertificated holdings or
despatch of certificates
8
Number and+class of all
+securities quoted on ASX
(including
the
securities
in
clause 2 if applicable)
9
Number and+class of all
+securities not quoted on ASX
(including
the
securities
in
clause 2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Yes. The new ordinary shares will rank equally
with the existing ordinary shares on issue
traded under ticker code PPS.
Yes. The new ordinary shares will rank equally
with the existing ordinary shares on issue
traded under ticker code PPS.
Nil.
Shares
were
issued
on
vesting
of
PerformanceRights.
Conversion of Performance Rights to Shares
under the Praemium Directors & Employees
Benefits Plan.
9 November 2011
Number +Class
292,938,278 292,871,611
- existing fully paid
ordinary shares, plus
66,667new fully paid
ordinary shares issued
Number +Class
10,977,285 Performance Rights &
Options (see detailed
table attached as
attachment A)
No change in dividend policy
  • See chapter 19 for defined terms.

Appendix 3B Page 2

1/1/2003

Part 2 - Bonus issue or pro rata issue

11 Is
security
holder
approval
required?
12 Is the issue renounceable or
non-renounceable?
13 Ratio in which the+securities
will be offered
14 +Class of +securities to which
the offer relates
15 +Record
date
to
determine
entitlements
16 Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17 Policy for deciding entitlements
in relation to fractions
18 Names of countries in which the
entity has+security holders who
will not be sent new issue
documents
Note: Security holders must be
told how their entitlements are to
be dealt with.
Cross reference: rule 7.7.
19 Closing date for receipt of
acceptances or renunciations
Names of any underwriters
21 Amount of any underwriting fee
or commission
22 Names of any brokers to the
issue
23 Fee or commission payable to
the broker to the issue
  • See chapter 19 for defined terms.

Appendix 3B Page 3

1/1/2003

24 Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of+security holders
25 If the issue is contingent on
+security holders’ approval, the
date of the meeting
26 Date
entitlement
and
acceptance form and prospectus
or Product Disclosure Statement
will be sent to persons entitled
27 If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
28 Date rights trading will begin (if
applicable)
29 Date rights trading will end (if
applicable)
30 How do+security holders sell
their entitlements_in full_through
a broker?
31 How do+security holders sell
_part_of their entitlements through
a broker and accept for the
balance?
32 How
do
+security
holders
dispose of their entitlements
(except
by
sale
through
a
broker)?
33 +Despatch date
  • See chapter 19 for defined terms.

Appendix 3B Page 4

1/1/2003

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities ( tick one )

  • (a) Securities described in Part 1

  • (b) All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional +securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

  • 38 Number of securities for which +quotation is sought

  • 39 Class of[+] securities for which quotation is sought

  • See chapter 19 for defined terms.

Appendix 3B Page 5

1/1/2003

40 Do the[+] securities rank equally in all respects from the date of allotment with an existing[+] class of quoted[+] securities?

If the additional securities do not rank equally, please state:

  • the date from which they do

  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

42 Number and +class of all +securities quoted on ASX ( including the securities in clause 38)

Number +Class

  • See chapter 19 for defined terms.

Appendix 3B Page 6

1/1/2003

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: Date: 10 November 2011 (Company secretary)

Print name: Paul Gutteridge

== == == == ==

  • See chapter 19 for defined terms.

24/10/2005 Appendix 3B Page 7

Attachment A

Part 1, Question 9

ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
ESOSAUS
Options – exercisable for $0.35c expiring 30
December 2011
31/12/2008
31/12/2011
$0.35
62,286
62,286
PPSOPT
Options – variable exercise price depending on
date of exercise - 15cents from 10/8/13 to 9/8/14,
25cents if exercised betw een 10/8/14 and 9/8/15,
and 35cents if exercised betw een 10/8/15 and
9/8/16
9/09/2011
9/08/2016
$0.15/ $0.25/ $0.35
1,000,000
1,000,000
Option Totals
1,062,286
0
0
0
1,062,286
ESP Code
Issue Date
No on Register on
24 October 2011
(Date of this 3B)
Expired / Cancelled /
Lapsed / Failure to
vest
Vested/ Exercised
Allocations
No on Register on
10 November 2011
(Date of this 3B)
Description (All issued pursuant to the Employee & Directo
Expiry Date
Issue Price
Performance Rights - nil exercise price Tranche 2 -
expire/vest 30/09/11
30/10/2010
30/10/2011
nil
712,500
712,500
Performance Rights - nil exercise price Tranche 3 -
expire/vest 30/09/12
30/10/2010 30/10/2012 nil 712,500 712,500
Performance Rights - nil exercise price Tranche 5 -
expire/vest 30/10/11
29/10/2010
30/10/2011
nil
50,000
50,000
Performance Rights - nil exercise price Tranche 6 -
expire/vest 30/10/12
1/06/2010 30/10/2012 nil 50,000 50,000
Performance Rights - nil exercise price Tranche 7A
- expire/vest 30/10/11
29/10/2010
30/10/2011
nil
100,000
100,000
Performance Rights - nil exercise price Tranche 7B
- expire/vest 30/10/12
29/10/2010 30/10/2012 nil 100,000 100,000
Performance
rights
(EMI
Options
(UK))
-
nil
exercise price Tranche 9 - Earliest Vest Date
(subject to satisfaction of performance conditions)
6/4/10
23/12/2010
1/12/2020
nil
1,336,668
(66,667)
1,270,001
Performance
rights
(EMI
Options
(UK))
-
nil
exercise price Tranche 10 - Earliest Vest Date
(subject to satisfaction of performance conditions)
30/10/11
23/12/2010 1/12/2020 nil 710,001 710,001
Performance
rights
(EMI
Options
(UK))
-
nil
exercise price Tranche 11 - Earliest Vest Date
(subject to satisfaction of performance conditions)
30/10/11
23/12/2010
1/12/2020
nil
709,997
709,997
Performance Rights (CFOT1) – nil exercise price –
Vest on date of issue of FY12 Annual report
(subject to satisfaction ofperformance conditions)
9/09/2011 30/09/2012 Nil 250,000 250,000
Performance Rights (CFOT2) – nil exercise price –
Vest on date of issue of FY13 Annual report
(subject to satisfaction ofperformance conditions)
9/09/2011
30/09/2013
Nil
125,000
125,000
Performance Rights (CEOT1) – nil exercise price –
Vest on date of issue of FY13 Annual report
(subject to satisfaction ofperformance conditions)
9/09/2011 30/09/2013 Nil 2,500,000 2,500,000
Performance Rights (CFOT3) – nil exercise price –
Vest on date of issue of FY14 Annual report
(subject to satisfaction ofperformance conditions)
9/09/2011
30/09/2014
Nil
125,000
125,000
Performance Rights (CEOT2) – nil exercise price –
Vest on date of issue of FY14 Annual report
(subject to satisfaction ofperformance conditions)
9/09/2011 30/09/2014 Nil 1,250,000 1,250,000
Performance Rights (CEOT2) – nil exercise price –
Vest on date of issue of FY15 Annual report
(subject to satisfaction ofperformance conditions)
9/09/2011
30/09/2015
Nil
1,250,000
1,250,000
Performance Rights(including EMI Options) Totals: 9,981,666 0 (66,667) 0 9,914,999
Number of securities on issue that are notquoted 11,043,952 0 (66,667) 0 10,977,285
  • See chapter 19 for defined terms.

Appendix 3B Page 8

1/1/2003